NCT04430972View on ClinicalTrials.gov

Immune Responsiveness and Outcome After Aortic Valve Surgery (Measure)

Not yet recruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2026

Conditions
Aortic Valve DiseaseSurgery--ComplicationsImmune System Disorder
Interventions
PROCEDURE

Aortic valve replacement

Open surgical replacement of aortic valve

Trial Locations (1)

EC1A 7BE

St Bartholomew's Hospital, London

All Listed Sponsors
collaborator

University College, London

OTHER

lead

Barts & The London NHS Trust

OTHER

NCT04430972 - Immune Responsiveness and Outcome After Aortic Valve Surgery (Measure) | Biotech Hunter | Biotech Hunter